Dr. Lestter Cruz Serrano is the Global Head of Medical Affairs in Cognizant Life Sciences group. He is also the global lead for Site Engagement team driving regional site adoption of various technology platform, like, Shared Investigator Platform (SIP), across regions in US, Canada, EU, ASIA-PAC, Africa and LATAM. He has led Cognizant’s efforts, in close collaboration with SIP Sponsors, to assist the most prestigious & large Academic Medical Centers around the world to adopt SIP.
Prior to this role, Dr. Cruz worked at CHI Health, where he led the Hematology and Oncology studies for the NIH Cooperative Group and Pharmaceutical Trials. He has also worked at Nebraska Medicine & the University of Nebraska Medical Center where he conducted phase II & III clinical trials for Diabetic, Endocrinology, Metabolic and Cardiovascular patients.
He received his M.D. degree from the UAG School of Medicine and trained as a Family physician. He is a Board Certified Medical Affairs Specialist and currently is working on his MBA.